Literature DB >> 11696480

Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection.

Z Qian1, R Gelzer-Bell, S X Yang Sx, W Cao, T Ohnishi, B A Wasowska, R H Hruban, E R Rodriguez, W M Baldwin, C J Lowenstein.   

Abstract

BACKGROUND: Inducible nitric oxide synthase (iNOS, or NOS2) reduces the severity of accelerated graft arteriosclerosis (AGA) in transplanted organs, although the precise mechanism is unclear. METHODS AND
RESULTS: We transplanted wild-type murine hearts into either wild-type or NOS2-null recipient mice; we then measured cardiac allograft survival and analyzed tissue sections by immunohistochemistry. We have confirmed that NOS2 increases cardiac allograft survival. We now show that there is less inflammation of cardiac allografts in wild-type hosts than in NOS2-null hosts. Furthermore, staining for von Willebrand factor reveals that the presence of NOS2 is correlated with the presence of Weibel-Palade bodies inside endothelial cells, whereas the absence of NOS2 is correlated with the release of Weibel-Palade bodies.
CONCLUSIONS: Weibel-Palade bodies contain mediators that promote thrombosis and inflammation. Therefore, nitric oxide (NO) may stabilize the vessel wall and prevent endothelial activation in part by inhibiting the release of the contents of Weibel-Palade bodies. Prevention of Weibel-Palade body release might be a mechanism by which NO protects the vessel wall from inflammatory disorders such as atherosclerosis or graft arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696480     DOI: 10.1161/hc4401.098471

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.

Authors:  Kenji Matsushita; Craig N Morrell; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

2.  Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells.

Authors:  Marcella Ferlito; Kaikobad Irani; Nauder Faraday; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-20       Impact factor: 11.205

3.  Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney.

Authors:  Takahiro Nakayama; Waichi Sato; Ashio Yoshimura; Li Zhang; Tomoki Kosugi; Martha Campbell-Thompson; Hideto Kojima; Byron P Croker; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

4.  HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.

Authors:  Munekazu Yamakuchi; James J M Greer; Scott J Cameron; Kenji Matsushita; Craig N Morrell; Karen Talbot-Fox; William M Baldwin; David J Lefer; Charles J Lowenstein
Journal:  Circ Res       Date:  2005-05-19       Impact factor: 17.367

5.  TNF-α-activated eNOS signaling increases leukocyte adhesion through the S-nitrosylation pathway.

Authors:  Gaynor Aguilar; Francisco Córdova; Tania Koning; José Sarmiento; Mauricio P Boric; Konstantin Birukov; Jorge Cancino; Manuel Varas-Godoy; Andrea Soza; Natascha G Alves; Patricio E Mujica; Walter N Durán; Pamela Ehrenfeld; Fabiola A Sánchez
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-15       Impact factor: 4.733

6.  JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.

Authors:  S Leah Etheridge; Michelle E Roh; Megan E Cosgrove; Veena Sangkhae; Norma E Fox; Junmei Chen; José A López; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 7.  The complex role of iNOS in acutely rejecting cardiac transplants.

Authors:  Galen M Pieper; Allan M Roza
Journal:  Free Radic Biol Med       Date:  2008-02-07       Impact factor: 7.376

8.  Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor.

Authors:  Kenji Matsushita; Craig N Morrell; Beatrice Cambien; Shui Xiang Yang; Munekazu Yamakuchi; Clare Bao; Makoto R Hara; Richard A Quick; Wangsen Cao; Brian O'Rourke; John M Lowenstein; Jonathan Pevsner; Denisa D Wagner; Charles J Lowenstein
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

9.  Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis.

Authors:  Kenji Matsushita; Munekazu Yamakuchi; Craig N Morrell; Michitaka Ozaki; Brian O'Rourke; Kaikobad Irani; Charles J Lowenstein
Journal:  Blood       Date:  2004-09-02       Impact factor: 22.113

10.  Relaxin protects rat lungs from ischemia-reperfusion injury via inducible NO synthase: role of ERK-1/2, PI3K, and forkhead transcription factor FKHRL1.

Authors:  Konstantin Alexiou; Manuel Wilbring; Klaus Matschke; Thomas Dschietzig
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.